Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Maintenance Treatment of Chronic Obstructive Pulmonary Disease, including chronic bronchitis and emphysema |
Dose: Ampoule inhaled via nebulization – 15 mcg (1 ampoule) Frequency: twice daily (morning and evening) Note: A total daily dose of greater than 30 mcg is not recommended. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment |
Dose: Dose adjustment not necessary Note: Renal Impairment Dose adjustment not necessary |
Administration
- For inhalation use only
- Use at same time each day
Side Effect
- Back pain (6%)
- Chest pain (7%)
- Diarrhea (6%)
- Dyspnea (4%)
- Flu syndrome (3%)
- Leg cramps (4%)
- Lung disorder (2%)
- Pain (8%)
- Peripheral edema (3%)
- Rash (4%)
- Sinusitis (5%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Hypersensitivity
|
Risk of severe allergic reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Arformoterol nebuliser solution should be stored at 2-8°C, protected from light and excessive heat. Do not freeze. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.